Results 191 to 200 of about 1,348,486 (207)

Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis

, 2019
Case Medical Research
openalex   +1 more source

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Cochrane Database of Systematic Reviews, 2016
N. Chande, C. Townsend, C. Parker, J. Macdonald   +3 more
semanticscholar   +1 more source

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

Science Translational Medicine, 2016
J. Rosenblatt, R. Stone, L. Uhl, D. Neuberg, R. Joyce, J. Levine, J. Arnason, Malgorzata McMasters, K. Luptakova, Salvia Jain, J. Zwicker, A. Hamdan, V. Boussiotis, D. Steensma, D. DeAngelo, I. Galinsky, Poorvi Somaiya Dutt, Emma K. Logan, Mary Paty Bryant, D. Stroopinsky, L. Werner, Kristen Palmer, M. Coll, Abigail Washington, L. Cole, D. Kufe, D. Avigan   +26 more
semanticscholar   +1 more source

Systematic review: second‐generation vs. conventional corticosteroids for induction of remission in ulcerative colitis

Alimentary Pharmacology and Therapeutics, 2016
G. D'Haens
semanticscholar   +1 more source

Immunomodulators and Advanced Therapies for Induction of Remission in Crohn’s Disease: A Systematic Review and Network Meta-Analysis

Vassiliki Sinopoulou, Morris Gordon, Shiyao Liu, Deijanira Albuquerque, Aderonke Ajiboye, Sudheer K. Vuyyuru, Shellie Radford, Gordon W. Moran   +7 more
openalex   +1 more source

Acute myeloid leukemia: a retrospective claims analysis of resource utilization and expenditures for newly diagnosed patients from first-line induction to remission and relapse

, 2016
William Irish, Michael P. Ryan, Larry Gache, Candace Gunnarsson, Timothy Bell, Mark Shapiro   +5 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysis

Gut, 2022
Objective There are numerous biological therapies and small molecules licensed for luminal Crohn’s disease (CD), but these are often studied in placebo-controlled trials, meaning relative efficacy is uncertain. We examined this in a network meta-analysis.
B. Barberio, D. Gracie, C. Black, A. Ford   +3 more
semanticscholar   +1 more source

Remission induction, maintenance, and endoscopic outcome with oral 5‐aminosalicylic acid in intestinal Behçet's disease

Journal of Gastroenterology and Hepatology, 2019
Oral 5‐aminosalicylic acid (5‐ASA) is recommended for the therapy of mild to moderate intestinal Behçet's disease (BD). However, the induction remission efficacy and endoscopic outcomes of 5‐ASA are unknown. We investigated remission induction at 8 weeks,
Hiroto Kinoshita, H. Nishioka, A. Ikeda, K. Ikoma, Y. Sameshima, H. Ohi, M. Tatsuno, J. Kouyama, C. Kawamoto, T. Mitsui, Y. Tamura, Y. Hashimoto, M. Nishio, T. Ogashiwa, Y. Saigusa, S. Maeda, H. Kimura, R. Kunisaki, K. Koike   +18 more
semanticscholar   +1 more source

The face of remission induction

British Journal of Haematology, 2019
Acute myeloid leukaemia (AML) is a heterogeneous disease in which prognosis is determined by cytogenetic and molecular aberrations as well as patient‐related factors, including age, prior haematologic disorders, and comorbidities.
Shilpa Paul, C. Rausch, E. Jabbour
semanticscholar   +1 more source

Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors

Arthritis & Rheumatology, 2017
X. Puéchal, C. Pagnoux, G. Baron, T. Quéméneur, A. Néel, C. Agard, F. Lifermann, E. Liozon, M. Ruivard, P. Godmer, N. Limal, A. Mékinian, T. Papo, A. Ruppert, A. Bourgarit, B. Bienvenu, L. Geffray, J. Saraux, E. Diot, B. Crestani, X. Delbrel, L. Sailler, P. Cohen, V. le Guern, B. Terrier, M. Groh, C. Le Jeunne, L. Mouthon, P. Ravaud, L. Guillevin   +29 more
semanticscholar   +1 more source